Is PT Diagnos Laboratorium stock a buy?

Yes, PT Diagnos Laboratorium pays dividends. Last time was Friday 27th of August 2021 where the investors holding the stock on Friday 6th of August 2021 were paid IDR4.8 per share. Over the last 1 times between 2021 and 2021, PT Diagnos Laboratorium has paid IDR4.8 with an average of IDR4.8 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for PT Diagnos Laboratorium 10 years ago, but if you had invested on Friday 15th of January 2021 when the price was IDR270.00, you would have made a profit of IDR14.00 per share or 5.19%

Yes, the average daily trading liquidity for PT Diagnos Laboratorium is IDR3.42 million. You should therefore be able to get in and out of your positions relatively fast.

PT Diagnos Laboratorium has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.43, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for PT Diagnos Laboratorium to be medium [0.6 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.